K220062

Substantially Equivalent

QIAstat-Dx Gastrointestinal Panel 2

Applicant: QIAGEN GmbH
Product code: PCH
Advisory panel: Microbiology
Date received: 2022-01-10
Decision date: 2024-05-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hilden, DE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.